Loading
Celyad Oncology Stock: price and insider trades · Belgium
Celyad Oncology: what insiders have been doing
Celyad Oncology has a thin disclosure history in our data (latest filing: 28 November 2024). New filings will appear here as soon as they are published. Source: insider filings from FSMA. Past trades are no guide to future returns.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 6,531 of 24,161 companies
63.0
score / 100
Value37
Quality89
FCF yld-46%
Earn yld5.5%
EV/EBITDA14.0x
ROE56%
Gross mgn62%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€0.26
Analyst consensus
Income statement
Revenue€21k
Gross profit€13k62% margin
EBITDA€1.1M5076% margin
Net income€830k3952.4% margin
Valuation
PER (trailing)13.1x
P/Book4.8x
Beta1.21
Balance sheet & cash
Market cap€11.7M
Free Cash Flow-€6.9M
Profitability & ownership
ROE56.3%
ROA-13.4%
% insiders10.3%
% institutions55.5%
Last declaration on 28 November 2024
Declarations6 total
10,000 shares@ €0.27100.0% of flowOptions /warrants for employees or managersOff exchangeISIN BE0974260896FSMA:celyad-oncology-4
1,035,714 shares@ €0.27100.0% of flowOptions /warrants for employees or managersOff exchangeISIN BE0974260896FSMA:celyad-oncology-2
10,000 shares@ €0.27100.0% of flowOptions /warrants for employees or managersOff exchangeISIN BE0974260896FSMA:celyad-oncology-3
30,000 shares@ €0.27100.0% of flowOptions /warrants for employees or managersOff exchangeISIN BE0974260896FSMA:celyad-oncology-0
10,000 shares@ €0.27100.0% of flowOptions /warrants for employees or managersOff exchangeISIN BE0974260896FSMA:celyad-oncology-1
6 of 6 declarations
About Celyad Oncology
Celyad Oncology is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It is listed on the XBRU market.
